1. The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation. Meyers S, Lenny N, Hiebert SW (1995) Mol Cell Biol 15(4): 1974-82
    › Primary publication · 7891692 (PubMed) · PMC230424 (PubMed Central)
  2. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. Frank R, Zhang J, Uchida H, Meyers S, Hiebert SW, Nimer SD (1995) Oncogene 11(12): 2667-74
    › Primary publication · 8545124 (PubMed)
  3. Indirect and direct disruption of transcriptional regulation in cancer: E2F and AML-1. Meyers S, Hiebert SW (1995) Crit Rev Eukaryot Gene Expr 5(3-4): 365-83
    › Primary publication · 8834231 (PubMed)
  4. Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia. Shurtleff SA, Meyers S, Hiebert SW, Raimondi SC, Head DR, Willman CL, Wolman S, Slovak ML, Carroll AJ, Behm F (1995) Blood 85(12): 3695-703
    › Primary publication · 7780153 (PubMed)
  5. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Golub TR, Barker GF, Bohlander SK, Hiebert SW, Ward DC, Bray-Ward P, Morgan E, Raimondi SC, Rowley JD, Gilliland DG (1995) Proc Natl Acad Sci U S A 92(11): 4917-21
    › Primary publication · 7761424 (PubMed) · PMC41818 (PubMed Central)
  6. Functional domains of the t(8;21) fusion protein, AML-1/ETO. Lenny N, Meyers S, Hiebert SW (1995) Oncogene 11(9): 1761-9
    › Primary publication · 7478604 (PubMed)
  7. E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis. Hiebert SW, Packham G, Strom DK, Haffner R, Oren M, Zambetti G, Cleveland JL (1995) Mol Cell Biol 15(12): 6864-74
    › Primary publication · 8524253 (PubMed) · PMC230941 (PubMed Central)
  8. PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2 beta/CBF beta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells. Nuchprayoon I, Meyers S, Scott LM, Suzow J, Hiebert S, Friedman AD (1994) Mol Cell Biol 14(8): 5558-68
    › Primary publication · 8035830 (PubMed) · PMC359075 (PubMed Central)
  9. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1. Roussel MF, Davis JN, Cleveland JL, Ghysdael J, Hiebert SW (1994) Oncogene 9(2): 405-15
    › Primary publication · 8290253 (PubMed)
  10. An E2F dominant negative mutant blocks E1A induced cell cycle progression. Dobrowolski SF, Stacey DW, Harter ML, Stine JT, Hiebert SW (1994) Oncogene 9(9): 2605-12
    › Primary publication · 8058324 (PubMed)